According to the research report, the global market for Human Varicella-Zoster Immunoglobulin should grow from US$ 159 million in 2022 to US$ 201.1 million by 2029, with a CAGR of 3.4% for the period of 2023-2029.

Herpes zoster is an acute herpetic viral skin disease caused by the varicella-zoster virus that involves the nerves and skin. Infected individuals treated with human water were less likely to develop severe varicella-zoster virus than those not treated with it.

Human varicella-zoster immune globulin is a solution of antibodies used for post exposure prophylaxis of varicella infections in high risk populations, as well as to reduce the severity of infections.

This report aims to provide a comprehensive study of the global market for Human Varicella-Zoster Immunoglobulin.
Key Takeaways and Highlights

(1) Global Human Varicella-Zoster Immunoglobulin market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Human Varicella-Zoster Immunoglobulin market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Human Varicella-Zoster Immunoglobulin market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Human Varicella-Zoster Immunoglobulin segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Human Varicella-Zoster Immunoglobulin segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Human Varicella-Zoster Immunoglobulin, capacity, production and trends.

(7) Human Varicella-Zoster Immunoglobulin industry supply chain, upstream, midstream and downstream analysis.

Regional Breakdown: Analyzing Market Segments by Geography

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Segmenting by Type: Comprehensive Coverage and Analysis

Freeze-dried Powder

Injection

Application-Based Segmentation: Unlocking Market Opportunities

Hospital

Clinic

In the Spotlight: A Closer Look at Market Players

Bio Products Laboratory

MassBiologics

Saol Therapeutics

Aptevo Biotherapeutics Llc

Ki Biopharma Llc

Cangene Biopharma

Kamada

Salmedon

1 Market Overview

1.1 Human Varicella-Zoster Immunoglobulin Definition

1.2 Global Human Varicella-Zoster Immunoglobulin Market Size and Forecast

1.2.1 By Revenue, Global Human Varicella-Zoster Immunoglobulin Market Size, 2018-2029

1.2.2 By Sales Volume, Global Human Varicella-Zoster Immunoglobulin Market Size, 2018-2029

1.2.3 Global Human Varicella-Zoster Immunoglobulin Price Trend, 2018-2029

1.3 China Human Varicella-Zoster Immunoglobulin Market Size and Forecast

1.3.1 By Revenue, China Human Varicella-Zoster Immunoglobulin Market Size, 2018-2029

1.3.2 By Sales Volume, China Human Varicella-Zoster Immunoglobulin Market Size, 2018-2029

1.3.3 China Human Varicella-Zoster Immunoglobulin Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Human Varicella-Zoster Immunoglobulin Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Human Varicella-Zoster Immunoglobulin Share in Global Market, 2018-2029

1.4.3 Human Varicella-Zoster Immunoglobulin Market Size: China VS Global, 2018-2029

1.5 Human Varicella-Zoster Immunoglobulin Market Dynamics

1.5.1 Human Varicella-Zoster Immunoglobulin Market Drivers

1.5.2 Human Varicella-Zoster Immunoglobulin Market Restraints

1.5.3 Human Varicella-Zoster Immunoglobulin Industry Trends

1.5.4 Human Varicella-Zoster Immunoglobulin Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Human Varicella-Zoster Immunoglobulin Revenue by Company, 2018-2023

2.2 Global Human Varicella-Zoster Immunoglobulin Sales Volume by Company, 2018-2023

2.3 Global Human Varicella-Zoster Immunoglobulin Price by Company, 2018-2023

2.4 Global Human Varicella-Zoster Immunoglobulin Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Human Varicella-Zoster Immunoglobulin Concentration Ratio

2.6 Global Human Varicella-Zoster Immunoglobulin Mergers & Acquisitions, Expansion Plans

2.7 Global Human Varicella-Zoster Immunoglobulin Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Human Varicella-Zoster Immunoglobulin Revenue by Company, 2018-2023

3.2 China Human Varicella-Zoster Immunoglobulin Sales Volume by Company, 2018-2023

3.3 China Human Varicella-Zoster Immunoglobulin Human Varicella-Zoster Immunoglobulin Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Human Varicella-Zoster Immunoglobulin Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Human Varicella-Zoster Immunoglobulin Domestic VS Export

3.6 China Market, Human Varicella-Zoster Immunoglobulin Import & Export

3.6.1 China Market, Human Varicella-Zoster Immunoglobulin Import & Export, 2018-2029

3.6.2 China Human Varicella-Zoster Immunoglobulin Import & Export Trends

3.6.3 Main Sources of China Human Varicella-Zoster Immunoglobulin Import

3.6.4 Export Destination of China Human Varicella-Zoster Immunoglobulin

4 Human Varicella-Zoster Immunoglobulin Production by Region

4.1 Global Human Varicella-Zoster Immunoglobulin Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Human Varicella-Zoster Immunoglobulin Manufacturers

4.3 Global Major Manufacturers, Human Varicella-Zoster Immunoglobulin Capacity Expansion and Future Plans

4.4 Global Human Varicella-Zoster Immunoglobulin Capacity by Region

4.5 Global Human Varicella-Zoster Immunoglobulin Production by Region

4.5.1 Global Human Varicella-Zoster Immunoglobulin Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Human Varicella-Zoster Immunoglobulin Production by Region, 2018-2023

4.5.3 Global Human Varicella-Zoster Immunoglobulin Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Human Varicella-Zoster Immunoglobulin Industry Chain

5.2 Human Varicella-Zoster Immunoglobulin Upstream Analysis

5.2.1 Human Varicella-Zoster Immunoglobulin Core Raw Materials

5.2.2 Main Manufacturers of Human Varicella-Zoster Immunoglobulin Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Human Varicella-Zoster Immunoglobulin Production Mode

5.6 Human Varicella-Zoster Immunoglobulin Procurement Model

5.7 Human Varicella-Zoster Immunoglobulin Industry Sales Model and Sales Channels

5.7.1 Human Varicella-Zoster Immunoglobulin Sales Model

5.7.2 Human Varicella-Zoster Immunoglobulin Typical Distributors

6 Sights by Type

6.1 Human Varicella-Zoster Immunoglobulin Classification

6.1.1 Freeze-dried Powder

6.1.2 Injection

6.2 By Type, Global Human Varicella-Zoster Immunoglobulin Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Human Varicella-Zoster Immunoglobulin Revenue, 2018-2029

6.4 By Type, Global Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029

6.5 By Type, Global Human Varicella-Zoster Immunoglobulin Price, 2018-2029

7 Sights by Application

7.1 Human Varicella-Zoster Immunoglobulin Segment by Application

7.1.1 Hospital

7.1.2 Clinic

7.2 By Application, Global Human Varicella-Zoster Immunoglobulin Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Human Varicella-Zoster Immunoglobulin Revenue, 2018-2029

7.4 By Application, Global Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029

7.5 By Application, Global Human Varicella-Zoster Immunoglobulin Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Human Varicella-Zoster Immunoglobulin Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Human Varicella-Zoster Immunoglobulin Revenue, 2018-2029

8.3 By Region, Global Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Human Varicella-Zoster Immunoglobulin Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Human Varicella-Zoster Immunoglobulin Market Size Market Share

8.5 Europe

8.5.1 Europe Human Varicella-Zoster Immunoglobulin Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Human Varicella-Zoster Immunoglobulin Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Human Varicella-Zoster Immunoglobulin Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Human Varicella-Zoster Immunoglobulin Market Size Market Share

8.7 South America

8.7.1 South America Human Varicella-Zoster Immunoglobulin Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Human Varicella-Zoster Immunoglobulin Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Human Varicella-Zoster Immunoglobulin Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Human Varicella-Zoster Immunoglobulin Revenue, 2018-2029

9.3 By Country, Global Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Human Varicella-Zoster Immunoglobulin Market Size, 2018-2029

9.4.2 By Company, U.S. Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Human Varicella-Zoster Immunoglobulin Market Size, 2018-2029

9.5.2 By Company, Europe Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022

9.5.3 By Type, Europe Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Human Varicella-Zoster Immunoglobulin Market Size, 2018-2029

9.6.2 By Company, China Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022

9.6.3 By Type, China Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Human Varicella-Zoster Immunoglobulin Market Size, 2018-2029

9.7.2 By Company, Japan Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022

9.7.3 By Type, Japan Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Human Varicella-Zoster Immunoglobulin Market Size, 2018-2029

9.8.2 By Company, South Korea Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Human Varicella-Zoster Immunoglobulin Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Human Varicella-Zoster Immunoglobulin Market Size, 2018-2029

9.10.2 By Company, India Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022

9.10.3 By Type, India Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Human Varicella-Zoster Immunoglobulin Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Human Varicella-Zoster Immunoglobulin Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Bio Products Laboratory

10.1.1 Bio Products Laboratory Company Information, Head Office, Market Area and Industry Position

10.1.2 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

10.1.3 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Bio Products Laboratory Company Profile and Main Business

10.1.5 Bio Products Laboratory Recent Developments

10.2 MassBiologics

10.2.1 MassBiologics Company Information, Head Office, Market Area and Industry Position

10.2.2 MassBiologics Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

10.2.3 MassBiologics Human Varicella-Zoster Immunoglobulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 MassBiologics Company Profile and Main Business

10.2.5 MassBiologics Recent Developments

10.3 Saol Therapeutics

10.3.1 Saol Therapeutics Company Information, Head Office, Market Area and Industry Position

10.3.2 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

10.3.3 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Saol Therapeutics Company Profile and Main Business

10.3.5 Saol Therapeutics Recent Developments

10.4 Aptevo Biotherapeutics Llc

10.4.1 Aptevo Biotherapeutics Llc Company Information, Head Office, Market Area and Industry Position

10.4.2 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

10.4.3 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Aptevo Biotherapeutics Llc Company Profile and Main Business

10.4.5 Aptevo Biotherapeutics Llc Recent Developments

10.5 Ki Biopharma Llc

10.5.1 Ki Biopharma Llc Company Information, Head Office, Market Area and Industry Position

10.5.2 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

10.5.3 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Ki Biopharma Llc Company Profile and Main Business

10.5.5 Ki Biopharma Llc Recent Developments

10.6 Cangene Biopharma

10.6.1 Cangene Biopharma Company Information, Head Office, Market Area and Industry Position

10.6.2 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

10.6.3 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Cangene Biopharma Company Profile and Main Business

10.6.5 Cangene Biopharma Recent Developments

10.7 Kamada

10.7.1 Kamada Company Information, Head Office, Market Area and Industry Position

10.7.2 Kamada Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

10.7.3 Kamada Human Varicella-Zoster Immunoglobulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Kamada Company Profile and Main Business

10.7.5 Kamada Recent Developments

10.8 Salmedon

10.8.1 Salmedon Company Information, Head Office, Market Area and Industry Position

10.8.2 Salmedon Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

10.8.3 Salmedon Human Varicella-Zoster Immunoglobulin Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Salmedon Company Profile and Main Business

10.8.5 Salmedon Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Human Varicella-Zoster Immunoglobulin Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Human Varicella-Zoster Immunoglobulin Market Restraints

Table 3. Human Varicella-Zoster Immunoglobulin Market Trends

Table 4. Human Varicella-Zoster Immunoglobulin Industry Policy

Table 5. Global Human Varicella-Zoster Immunoglobulin Revenue by Company, 2018-2023, US$ million

Table 6. Global Human Varicella-Zoster Immunoglobulin Revenue Market Share by Company, 2018-2023

Table 7. Global Human Varicella-Zoster Immunoglobulin Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Human Varicella-Zoster Immunoglobulin Sales Volume Market Share by Company, 2018-2023

Table 9. Global Human Varicella-Zoster Immunoglobulin Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Human Varicella-Zoster Immunoglobulin Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Human Varicella-Zoster Immunoglobulin Mergers & Acquisitions, Expansion Plans

Table 12. Global Human Varicella-Zoster Immunoglobulin Manufacturers Product Type

Table 13. China Human Varicella-Zoster Immunoglobulin Revenue by Company, 2018-2023, US$ million

Table 14. China Human Varicella-Zoster Immunoglobulin Revenue Market Share by Company, 2018-2023

Table 15. China Human Varicella-Zoster Immunoglobulin Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Human Varicella-Zoster Immunoglobulin Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Human Varicella-Zoster Immunoglobulin Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Human Varicella-Zoster Immunoglobulin Import & Export Trends

Table 19. Main Sources of China Human Varicella-Zoster Immunoglobulin Import

Table 20. Export Destination of China Human Varicella-Zoster Immunoglobulin

Table 21. Global Headquarters and Manufacturing Base of Human Varicella-Zoster Immunoglobulin Manufacturers

Table 22. Global Major Manufacturers, Human Varicella-Zoster Immunoglobulin Capacity Expansion and Future Plans

Table 23. Global Human Varicella-Zoster Immunoglobulin Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Human Varicella-Zoster Immunoglobulin Production by Region, 2018-2023, (K Units)

Table 25. Global Human Varicella-Zoster Immunoglobulin Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Human Varicella-Zoster Immunoglobulin Upstream (Raw Materials)

Table 27. Global Human Varicella-Zoster Immunoglobulin Typical Customers

Table 28. Human Varicella-Zoster Immunoglobulin Typical Distributors

Table 29. By Type, Global Human Varicella-Zoster Immunoglobulin Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Human Varicella-Zoster Immunoglobulin Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Human Varicella-Zoster Immunoglobulin Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Human Varicella-Zoster Immunoglobulin Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Human Varicella-Zoster Immunoglobulin Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Human Varicella-Zoster Immunoglobulin Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Human Varicella-Zoster Immunoglobulin Revenue Market Share, 2018-2029

Table 37. By Country, Global Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2018-2029

Table 39. Bio Products Laboratory Company Information, Head Office, Market Area and Industry Position

Table 40. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

Table 41. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Bio Products Laboratory Company Profile and Main Business

Table 43. Bio Products Laboratory Recent Developments

Table 44. MassBiologics Company Information, Head Office, Market Area and Industry Position

Table 45. MassBiologics Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

Table 46. MassBiologics Human Varicella-Zoster Immunoglobulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. MassBiologics Company Profile and Main Business

Table 48. MassBiologics Recent Developments

Table 49. Saol Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 50. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

Table 51. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Saol Therapeutics Company Profile and Main Business

Table 53. Saol Therapeutics Recent Developments

Table 54. Aptevo Biotherapeutics Llc Company Information, Head Office, Market Area and Industry Position

Table 55. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

Table 56. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Aptevo Biotherapeutics Llc Company Profile and Main Business

Table 58. Aptevo Biotherapeutics Llc Recent Developments

Table 59. Ki Biopharma Llc Company Information, Head Office, Market Area and Industry Position

Table 60. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

Table 61. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Ki Biopharma Llc Company Profile and Main Business

Table 63. Ki Biopharma Llc Recent Developments

Table 64. Cangene Biopharma Company Information, Head Office, Market Area and Industry Position

Table 65. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

Table 66. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Cangene Biopharma Company Profile and Main Business

Table 68. Cangene Biopharma Recent Developments

Table 69. Kamada Company Information, Head Office, Market Area and Industry Position

Table 70. Kamada Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

Table 71. Kamada Human Varicella-Zoster Immunoglobulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Kamada Company Profile and Main Business

Table 73. Kamada Recent Developments

Table 74. Salmedon Company Information, Head Office, Market Area and Industry Position

Table 75. Salmedon Human Varicella-Zoster Immunoglobulin Models, Specifications and Application

Table 76. Salmedon Human Varicella-Zoster Immunoglobulin Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Salmedon Company Profile and Main Business

Table 78. Salmedon Recent Developments

List of Figure

Figure 1. Human Varicella-Zoster Immunoglobulin Picture

Figure 2. By Revenue, Global Human Varicella-Zoster Immunoglobulin Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Human Varicella-Zoster Immunoglobulin Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Human Varicella-Zoster Immunoglobulin Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Human Varicella-Zoster Immunoglobulin Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Human Varicella-Zoster Immunoglobulin Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Human Varicella-Zoster Immunoglobulin Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Human Varicella-Zoster Immunoglobulin Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Human Varicella-Zoster Immunoglobulin Share of Global Market, 2018-2029

Figure 10. Global Human Varicella-Zoster Immunoglobulin Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Human Varicella-Zoster Immunoglobulin Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Human Varicella-Zoster Immunoglobulin Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Human Varicella-Zoster Immunoglobulin Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Human Varicella-Zoster Immunoglobulin Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Human Varicella-Zoster Immunoglobulin Domestic VS Export, 2022

Figure 16. Global Human Varicella-Zoster Immunoglobulin Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Human Varicella-Zoster Immunoglobulin Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Human Varicella-Zoster Immunoglobulin Production Market Share & Forecast by Region, 2018-2029

Figure 19. Human Varicella-Zoster Immunoglobulin Industry Chain

Figure 20. Human Varicella-Zoster Immunoglobulin Procurement Model

Figure 21. Human Varicella-Zoster Immunoglobulin Sales Model

Figure 22. Human Varicella-Zoster Immunoglobulin Sales Channels, Direct Sales and Distribution

Figure 23. Freeze-dried Powder

Figure 24. Injection

Figure 25. By Type, Global Human Varicella-Zoster Immunoglobulin Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global Human Varicella-Zoster Immunoglobulin Revenue Market Share, 2018-2029

Figure 27. By Type, Global Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029, (K Units)

Figure 28. By Type, Global Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global Human Varicella-Zoster Immunoglobulin Price, 2018-2029, (US$/Unit)

Figure 30. Hospital

Figure 31. Clinic

Figure 32. By Application, Global Human Varicella-Zoster Immunoglobulin Revenue, 2018-2029, US$ Million

Figure 33. By Application, Global Human Varicella-Zoster Immunoglobulin Revenue Market Share, 2018-2029

Figure 34. By Application, Global Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029, (K Units)

Figure 35. By Application, Global Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2018-2029

Figure 36. By Application, Global Human Varicella-Zoster Immunoglobulin Price, 2018-2029, (US$/Unit)

Figure 37. By Region, Global Human Varicella-Zoster Immunoglobulin Revenue Market Share, 2018-2029

Figure 38. By Region, Global Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2018-2029

Figure 39. North America Human Varicella-Zoster Immunoglobulin Revenue & Forecasts, 2018-2029, US$ Million

Figure 40. By Country, North America Human Varicella-Zoster Immunoglobulin Revenue Market Share, 2022

Figure 41. Europe Human Varicella-Zoster Immunoglobulin Revenue & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, Europe Human Varicella-Zoster Immunoglobulin Revenue Market Share, 2022

Figure 43. Asia Pacific Human Varicella-Zoster Immunoglobulin Revenue & Forecasts, 2018-2029, US$ Million

Figure 44. By Country/Region, Asia Pacific Human Varicella-Zoster Immunoglobulin Revenue Market Share, 2022

Figure 45. South America Human Varicella-Zoster Immunoglobulin Revenue & Forecasts, 2018-2029, US$ Million

Figure 46. By Country, South America Human Varicella-Zoster Immunoglobulin Revenue Market Share, 2022

Figure 47. Middle East & Africa Human Varicella-Zoster Immunoglobulin Revenue & Forecasts, 2018-2029, US$ Million

Figure 48. U.S. Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029, (K Units)

Figure 49. By Company, U.S. Human Varicella-Zoster Immunoglobulin Market Share, 2022

Figure 50. By Type, U.S. Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 51. By Application, U.S. Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 52. Europe Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029, (K Units)

Figure 53. By Company, Europe Human Varicella-Zoster Immunoglobulin Market Share, 2022

Figure 54. By Type, Europe Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 55. By Application, Europe Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 56. China Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029, (K Units)

Figure 57. By Company, China Human Varicella-Zoster Immunoglobulin Market Share, 2022

Figure 58. By Type, China Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 59. By Application, China Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 60. Japan Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029, (K Units)

Figure 61. By Company, Japan Human Varicella-Zoster Immunoglobulin Market Share, 2022

Figure 62. By Type, Japan Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 63. By Application, Japan Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 64. South Korea Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029, (K Units)

Figure 65. By Company, South Korea Human Varicella-Zoster Immunoglobulin Market Share, 2022

Figure 66. By Type, South Korea Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 67. By Application, South Korea Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 68. Southeast Asia Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029, (K Units)

Figure 69. By Company, Southeast Asia Human Varicella-Zoster Immunoglobulin Market Share, 2022

Figure 70. By Type, Southeast Asia Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 71. By Application, Southeast Asia Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 72. India Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029, (K Units)

Figure 73. By Company, India Human Varicella-Zoster Immunoglobulin Market Share, 2022

Figure 74. By Type, India Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 75. By Application, India Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 76. Middle East & Asia Human Varicella-Zoster Immunoglobulin Sales Volume, 2018-2029, (K Units)

Figure 77. By Company, Middle East & Asia Human Varicella-Zoster Immunoglobulin Market Share, 2022

Figure 78. By Type, Middle East & Asia Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 79. By Application, Middle East & Asia Human Varicella-Zoster Immunoglobulin Sales Volume Market Share, 2022 VS 2029

Figure 80. Research Methodology

Figure 81. Breakdown of Primary Interviews

Figure 82. Bottom-up Approaches

Figure 83. Top-down Approaches